Benign Prostatic Hyperplasia Procedures Research Report by Leading Key Players - Boston Scientific, Urologix, Karl Storz GmbH & Co KG, Lumenis, Medtronic

Benign Prostatic Hyperplasia (BPH) Procedures are expected to grow at a CAGR of 2.3% during 2017 – 2023, according to P&S Market Research

Increasing life expectancy and fall in the birth rates are the major reasons for rise in the aging population. The people in this category require extensive care, since they are more prone to illness due to low immunity levels and longer recovery time. Increase in the aging population in the U.S., Germany, China and India in the next few years, is expected to create high demand for BPH treatment devices, since the population aged 50 years and above is more prone to BPH, and therefore tend to opt for various treatments that involve the use of procedures such as TURP, prostate implants and laser based treatments. Thus, growing aging population acts as a strong driver supporting the increase in the number of BPH procedures performed.

Access Detailed Report Summary at: https://www.psmarketresearch.com/market-analysis/benign-prostatic-hyperplasia-procedures

According to the National Institute of Health, it has been estimated that around 14 million men in the U.S. had symptoms suggestive of BPH, which can affect 50% of men aged between 51 and 60 years of age, and up to 90% of men aged more than 80 years. With 50% of men getting affected with BPH, there is a consequent increase in the BPH procedures.

Download Report Sample at: https://www.psmarketresearch.com/market-analysis/benign-prostatic-hyperplasia-procedures/report-sample

Geographically, Europe accounted for the largest number of BPH procedures done in 2016. Growing ageing population, lower cost of BPH treatment as compared to the U.S., high healthcare spending, and technological advancements in the field of urological procedures technology are some of the factors driving the growth of the BPH procedures in the Europe. France, Germany and the U.K. are expected to be the most promising countries for the growth in number of the BPH procedures. In June 2016, National Institute of Health and Care Excellence (NICE) approved GreenLight XPS laser treatment for the treatment of BPH. NICE added that the widespread adoption of the procedure could save the National Health Services (NHS) an estimated $4.3 million (£3 million) a year. Asia-Pacific is expected to witness the high number of BPH procedures performed during the forecast period, owing to the rising prevalence of BPH disorders, increasing disposable income, aging population, and growing efforts to increase awareness about advanced BPH treatment procedures.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=benign-prostatic-hyperplasia-procedures

Additionally, another example of technologically advanced BPH treatment devices include Dr Allen’s device for prostate care and ProVerum, which is used to restore function of the urethra in BPH to allow patients with this condition to urinate normally, relieving their symptoms while not interfering with sexual function. Dr Allen’s device uses thermobalancing therapy, which is different from other heating treatments as it does not regulate localized temperature.

Some of the other key players operating in the global BPH procedures include NxThera, Inc., Boston Scientific Corporation, Urologix, LLC., Karl Storz GmbH & Co. KG, Lumenis Ltd., Olympus Corporation, Advin Urology, Convergent Laser Technologies, Richard Wolf GmbH, Medtronic Plc.

GLOBAL BPH PROCEDURES SEGMENTATION
By Type
• Surgical procedure
o Transurethral resection of the prostate (TURP)
o Transurethral incision of the prostate (TUIP)
• Laser based procedure
o Holmium lasers
o Green light lasers
o Thulium lasers
o Others
• Other energy based procedure
o Transurethral microwave thermotherapy (TUMT)
o Transurethral needle ablation (TUNA)
o High-intensity focused ultrasound (HIFU) and water-induced thermotherapy
o Others

By End User
• Hospitals
• Specialty clinics
• Ambulatory surgery centers

By Geography
• North America
o The U.S.
o Canada
• Europe
o France
o Germany
o The U.K.
o Italy
o Spain
o Rest of Europe

• Asia-Pacific
o Australia
o Japan
o South Korea
o Rest of Asia-Pacific

• RoW

About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.